Dipeptidyl peptidase-4 inhibitors, pancreatic cancer and acute pancreatitis: A meta-analysis with trial sequential analysis
The priorities are getting GLP-1 Alternatives When You Cant Tolerate the Side Effects If GLP-1 side effects like nausea are making treatment hard to stick with, you have options before giving up
Helms ER, Aragon AA, Fitschen PJ
GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1 receptor agonists, including Ozempic, Semaglutide, and Rybelsus, have surged over the last five years as their effectiveness in promoting weight loss gains attention beyond type 2 diabetes care
This was not only the case in the United States but also in low and middle income countries
DAVID KESSLER: We need to use the playbook again, but we also need to be able to give people, if they want, the ability to reclaim their health